Copper particles were incorporated into nanofibers during the electrospinning of poly-D,L-lactide (PDLLA) and poly(ethylene oxide) (PEO). The ability of the nanofibers to prevent Pseudomonas aeruginosa PA01 and Staphylococcus aureus (strain Xen 30) to form biofilms was tested. Nanofibers containing copper particles (Cu-F) were thinner (326 ± 149 nm in diameter), compared to nanofibers without copper (CF; 445 ± 93 nm in diameter). The crystalline structure of the copper particles in Cu-F was confirmed by X-ray diffraction (XRD). Copper crystals were encapsulated, but also attached to the surface of Cu-F, as shown scanning transmission electron microscopy (STEM) and transmission electron microscopy (TEM), respectively. The copper particles had no effect on the thermal degradation and thermal behaviour of Cu-F, as shown by thermogravimetric analysis (TGA) and differential scanning calorimeter (DSC). After 48 h in the presence of Cu-F, biofilm formation by P. aeruginosa PA01 and S. aureus Xen 30 was reduced by 41% and 50%, respectively. Reduction in biofilm formation was ascribed to copper released from the nanofibers. Copper-containing nanofibers may be incorporated into wound dressings.
Citation: Ahire JJ, Hattingh M, Neveling DP, Dicks LMT (2016) Copper-Containing Anti-Biofilm Nanofiber Scaffolds as a Wound Dressing Material. PLoS ONE11(3): e0152755. https://doi.org/10.1371/journal.pone.0152755
Editor: Abdelwahab Omri, Laurentian, CANADA
Received: February 2, 2016; Accepted: March 18, 2016; Published: March 30, 2016
Copyright: © 2016 Ahire et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper.
Funding: This work was supported by the TraceXtec (Pty) Ltd, South Africa, for financial support and Divann Robertson for assistance with DSC and TGA analyses. Jayesh J Ahire is grateful to Stellenbosch University, South Africa, for a postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The commercial funding received does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Copper is an essential metal and is required in small quantities in many metabolic processes [1, 2]. Under controlled conditions, copper plays an important role in wound healing by enhancing the expression of integrin, and stabilizing fibrinogen and collagen formation [1, 3–7]. Excessive use of copper is toxic, as it generates free radicals by the Fenton and Haber-Weiss reaction, which may lead to lipid peroxidation and cell death [8, 9]. However, copper-transporting adenosine triphosphatases (Cu-ATPases), such as ATP7A and ATP7B in humans, maintain the homeostasis and excrete copper through the intestine, liver and mammary glands [10–12]. In a more recent study with bacterial cells, it was shown that copper nanoparticles causes protein oxidation and DNA degradation .
In ancient times, copper was used to sterilize water and treat burn, skin and ear infections . Intra-uterine copper devices have been in use for many years  and in 2008 the US Environmental Protection Agency (USEPA) permitted the use of copper alloys to control microbial growth . Most pathogens, including strains of Pseudomonas aeruginosa, Enterobacter aerogenes, Staphylococcus aureus, methicillin-resistant S. aureus (MRSA), vancomycin-resistant Enterococcus (VRE), Clostridium difficile, Salmonella enterica, Campylobacter jejuni and Escherichia coli 0157:H7, are killed when exposed to the surfaces of copper and copper alloys [16–22]. Copper oxide-impregnated dressings enhanced wound healing in genetically engineered diabetic mice .
Exopolysaccharides (EPS) safeguard cells from antibiotics, antimicrobial peptides and harsh environmental conditions [23, 24]. At least two reports published last year suggested treatment of biofilms with copper-containing nanoparticles [25, 26]. To the best of our knowledge, the incorporation of copper into nanofibers and its effect on biofilms has not been reported.
Silver is well known for its antimicrobial activity and silver nanoparticles (Ag-NPs) incorporated into nanofiber dressings have been used in wound dressings [9, 27–29]. In this paper we describe the electrospinning of copper particles into biodegradable nanofibers prepared from a 1:1 combination of poly-D,L-lactide (PDLLA) and poly(ethylene oxide) (PEO). Antimicrobial properties of copper-containing nanofibers (Cu-F) were tested against biofilms of P. aeruginosa PA01 and a methicillin-resistant S. aureus, strain Xen 30.
Materials and Methods
Copper powder was supplied by TraceXtec (TraceXtec, Pty., Ltd., South Africa). PDLLA (Mw 75−120 kDa) and PEO (Mw 200 kDa), N,N-dimethylformamide (DMF), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), Dulbecco’s modified Eagle's medium (DMEM), Hams-F12, fetal bovine serum (FBS), hydrocortisone, insulin, cholera toxin and PenStrep were obtained from Sigma-Aldrich (St. Louis, MO, USA). The LIVE/DEAD® BaclightTM Bacterial Viability kit and FilmTracerTM SYPRO® Ruby Biofilm Matrix Stain were from Thermo Fisher Scientific (Massachusetts, USA). All reagents were of analytical grade.
Preparation of copper-containing nanofibers
A 24% (w/v) 1:1 combination of PDLLA and PEO, dissolved in DMF, was heated at 40°C to produce a homogenous solution. Copper powder was suspended in the polymer solution to the final concentration of 150 mg ml−1. Initial studies have shown that this was the maximum concentation of copper particles that could be electrospun into nanofibers. Nanofibers were electrospun as described by Heunis et al. . PDLLA/PEO nanofibers without copper powder served as control.
Characterization of nanofibers
Nanofibers were sputter-coated with carbon and their surface morphology visualised by scanning electron microscopy (SEM), using a FEI Nova nanoSEM 230 (FEI, Hillsboro, Oregon, USA). A total of 100 image points were measured to determine the average diameter of the nanofibers. ImageJ Software (version 1.46, Scion Corporation, Maryland, USA) was used. Transmission electron microscopy (TEM) images were recorded on a Philips Tecnai TF20 (FEI).Copper particles in nanofibers was visualised using a FEI Nova nanoSEM 230 (FEI), equipped with an X/Max Oxford energy-dispersive X-ray (EDX) detector (Oxford Instruments, Oxfordshire, UK). INCA software (Berkshire, UK) was used to analyse the EDX spectra. Scanning transmission electron microscopy (STEM) images were recorded using the FEI Nova nanoSEM 230, equipped with STEM detector. Physical phases were observed by X-ray diffraction (XRD) using a Bruker AXS D8 Advance X-ray diffractometer (Bruker AXS, Frankfurt, Germany), equipped with a Vantec-1 position sensitive detector (Cu-Kα radiation at λ = 1.5406 Å) and operated in locked coupled mode. The X-ray tube was operated at 40 mA and 40 kV. Readings were recorded at a scanning rate of 88 sec/step, with a step size of 0.05° in a 2θ range that extended from 15° to 95°. The thermal stability, melting endotherms and crystallization exotherms of nanofibers were measured by thermogravimetric analyser (TGA) and differential scanning calorimeter (DSC), as described by Ahire et al. .
In vitro antimicrobial activity
Active-growing cells of P. aeruginosa PA01 and S. aureus Xen 30 (105 CFU ml–1) were each spread-plated onto Muller-Hinton agar (Fluka, Sigma-Aldrich Pty, Ltd., Aston Manor, South Africa). Sections of 0.5 cm2 copper-containing nanofibers (Cu-F) and nanofibers without copper (CF) were placed on the surface of the spread plates and the plates incubated at 37°C for 24 h. The diameter of growth inhibition zones was measured in millimetres.
Biofilm formation in the presence of nanofibers
Pseudomonas aeruginosa PA01 and S. aureus Xen 30 (Caliper Life Sciences, Hopkinton, USA) were stimulated to form biofilms, as described by Ahire and Dicks [32, 33]. Sections of Cu-F (0.5 cm2) were placed in 24 wells of a 96-well plastic round-bottom multidish (Corning, Sigma-Aldrich Pty, Ltd.). Another 24 wells received CF (0.5 cm2). Cell suspensions of P. aeruginosa PA01 and S. aureus Xen 30 were prepared in sterile tryptone soy broth (TSB, Biolab Diagnostics, Biolab, Midrand, South Africa) to 7.3 ± 0.07 log 10 CFU ml–1 and 6.6 ± 0.11 log 10 CFU ml–1, respectively. Two-hundred microliters of the P. aeruginosa PA01 cell suspension was transferred to 12 wells containing Cu-F and 12 wells containing CF. Twelve wells with Cu-F and 12 wells with CF were each inoculated with 200 μl S. aureus Xen 30 cell suspension. Twelve wells without nanofibers were inoculated with 200 μl P. aeruginosa PA01 and another 12 wells with the same volume S. aureus Xen 30. All plates were statically incubated at 37°C for 48 h.
At specific time intervals, nanofibers and planktonic cells were carefully removed from the wells and discarded. The wells were then washed twice with sterile distilled water and air dried. Total biofilm formation was determined by staining the wells with crystal violet [32, 33]. Optical density readings were taken at 595 nm.
Number of viable cells in biofilms
Sterile PBS, pH 7.3 (100 μl) was added to wells immediately after washing with sterile distilled water. The cells were carefully suspended by using a sterile glass rod, the suspension serially diluted in PBS and plated onto TSA (Biolab). Colonies were counted after 24 h of incubation at 37°C.
Confocal laser scanning microscopy (CLSM) of biofilms
Immediately after washing the cells with sterile distilled water, biofilms were carefully removed from the wells with a sterile pipette tip and transferred to 100 μl sterile PBS (pH 7.3). The biofilms were stained with the LIVE/DEAD® BaclightTM Bacterial Viability kit (Thermo Fisher Scientific, Massachusetts, USA) and FilmTracerTM SYPRO® Ruby Biofilm Matrix Stain (Thermo Fisher Scientific), as recommended by the suppliers. A Carl Zeiss LSM780 confocal microscope (Carl Zeiss, Göttingen, Germany) was used to study the stained biofilms. Images were processed by using the ZEN 2011 imaging software (Carl Zeiss).
Surface characterization of biofilms
Wells that contained biofilms were washed and dried as described elsewhere. After drying, the wells were cut out with a sharp blade and images of the wells taken with a FEI Nova nanoSEM 230 (FEI). The topology of the surfaces was studied using a Nanosurf Easyscan 2 atomic force microscope (AFM; Nanosurf AG, Switzerland). The AFM was operated in static force mode, equipped with a CantAI-G cantilever. The P-gain was adjusted to 2800, rotation to 45° and tip voltage to zero. Images were recorded in the range of 10 μm (x and y) and AFM parameters were evaluated using the SPIP 3D image processing 6.3.6 software (Image Metrology A/S, Hørsholm, Denmark).
Controlled release of copper
Sections of Cu-F (10 mg) were each submersed in 1 ml sterile deionized water and incubated at 25°C. The nanofiber mat was transferred to sterile deionized water, every 2 h, for up to 24 h. Release of copper from the nanofiber mats was studied with inductively-coupled plasma mass spectrometry (ICP-MS), using an Agilent 7700 ICP-MS (Agilent Technologies, München, Germany).
In vitro cytotoxicity
The cytotoxicity of nanofibers was performed as described by Ahire et al. . Briefly, breast epithelial cells (MCF-12A) were cultured in DMEM and Hams-F12 (1:1), supplemented with 10% FBS, 0.5 μg ml–1 hydrocortisone, 10 μg ml–1 insulin, 100 ng ml–1 cholera toxin and 1% (v/v) PenStrep. Cells were seeded in 12 × 24-well NEST tissue culture plates (Nest Biotechnology, Wuxi Jiangsu, China) to 8.0 × 104 per well and incubated at 37°C in humidified atmosphere (5% CO2). After 24 h, the medium in wells was replaced with UV-sterilized Cu-F (0.5 cm2), CF (0.5 cm2), and fresh culture media (negative control, NC), respectively. The plates were incubated for a further 24 h, after which cell viability was determined using the MTT assay.
All experiments were performed in triplicate. Values are expressed as mean ± standard deviation (SD). One-way analysis of variance (ANOVA) was calculated by using GraphPad Prism (6.07-Trial, GraphPad Software Inc,CA, USA). A P value < 0.05 or less was considered statistically significant.
Results and Discussion
Characterization of nanofibers
Copper particles in the PDLLA/PEO solution accelerated a liquid jet towards a grounded collector, due to an increase in conductance. Similar findings were reported with the presence of copper nanoparticles during the spinning of polyurethane nanofibers . This explains the smaller diameter of Cu-F (average 326 ± 149 nm) compared to CF (average 445 ± 93 nm). The choice of solvent, distance between needle and collector has a major effect on fiber morphology. As the solvent evaporates, the liquid jet is stretched to many times its original length to produce continuous, ultrathin, fibers of the polymer . Apart from a more gold-coloured Cu-F, the structure of Cu-F and CF were identical when visualised under the SEM (Fig 1A and 1B). Images recorded with TEM clearly showed copper particles encapsulated in nanofibers (Fig 1D, right arrow), but also attached to the surface of the fibers (Fig 1D, left arrow). Images obtained with STEM confirmed the inclusion of copper particles in the fibers (Fig 1F, both arrows). No selected area electron diffraction pattern (SAED) was detected for copper. The irregular shape of the copper particles, recorded with SEM and TEM, before electrospinning, is shown in Fig 1C and 1E, respectively. The irregular shape and size of the copper particles resulted in an uneven distribution of the particles in the polymer and thus also the nanofibers. The irregular morphology of the copper particles is ascribed to the method used to produce particles from metal sheets.
Scanning electron microscopy (SEM) images of (a) control nanofibers (CF), (b) copper-containing nanofibers (Cu-F) and (c) copper particles before electrospinning. Digital images of the electrospun nanofiber mats and copper powder are shown as inserts. The TEM image of Cu-F (d) shows the encapsulation of copper crystals (right arrow) in nanofibers and the attachment of crystals on the surface (left arrow) of the fibers. Image (e) is the same as (c), but visualised with TEM. Image (f) is the same as (d), but recorded with STEM and shows the inclusion of copper crystals of different sizes in Cu-F (two arrows).
Analyses with SEM-energy-dispersive X-ray (EDX) of Cu-F (Fig 2B) and copper particles (Fig 2C) revealed the presence of C, O, Cu, and Zn (Fig 2E and 2F). In addition, trace quantities of Al (0.43 ± 0.41 wt. %) were also detected in copper particles (Fig 2C and 2F). Analyses of CF showed C and O as major elements, with small quantities (0.45 ± 0.12 wt. %) of Si (Fig 2A and 2D).
SEM-energy-dispersive X-ray (EDX) analysis of (a) nanofibers without copper (CF), (b) copper-containing nanofibers (Cu-F) and (c) copper particles. The EDX scan spectra of selected areas pointed out in images (a), (b) and (c) are shown in (d), (e) and (f), respectively. The percentages shown for each of the elements are the mean of three selected areas from SEM images.
Diffraction peaks at 2θ values of 43.12°, 50.10°, 74.0°, and 89.6° recorded with XRD corresponded to (111), (200), (220) and (311) crystal planes (Fig 3) of the JCPDS database . These results confirmed the crystalline structure of copper in the nanofibers.
With TGA analyses (Fig 4A), two distinct weight losses were observed for CF and may be attributed to the PDLLA (50 wt. %) and PEO (50 wt. %) homo-polymers, respectively . The addition of copper particles had no major effect on the thermal degradation of the nanofibers. Similar to the CF, two weight losses were visible until 40% of the original weight remained. This implies that the sample had a copper content of 40 wt. %, as neat copper was stable throughout the entire temperature range. No thermal events were observed in DSC for neat copper within the operating temperature range. The melting endotherms and crystallization exotherms recorded for Cu-F were similar to those observed for CF, indicating that the copper particles had no effect on the thermal behaviour of the samples (Fig 4B).
In vitro antimicrobial activity
Copper-containing nanofibers (Cu-F) placed on the surface of plates inhibited the growth of P. aeruginosa PA01 (inhibition zone diameter: 5 ± 1.1 mm) and methicillin resistant S. aureus Xen 30 (inhibition zone diameter: 12 ± 1.5 mm). Nanofibers without copper particles (CF) did not inhibit the growth of the two species and confirmed previous findings [31–34, 38, 27]. The smaller inhibition zone recorded for P. aeruginosa PA01 is ascribed to the strain’s natural resistance to copper . Resistance to copper may be due to less negatively charged peptidoglycan in the cell wall . The outer membrane of Gram-negative bacteria act as barrier to protect the cell from the penetration of biocides and antibiotics . Accumulation of high levels of copper in the cytoplasm induces a Fenton and Haber-Weiss reaction that mediates lipid peroxidation and cell death [8, 42]. The oxidation product of metallic copper, i.e. Cu2+, is known to oxidise proteins and degrade DNA . Similar mechanisms of antimicrobial activity have been reported for Ag-NPs . Silver particles electrospun into PDLLA: PEO inhibited P. aeruginosa PA01 and methicillin resistant S. aureus Xen 30 . The difference in antimicrobial activity observed between copper and silver particles incorporated into nanofibers may be due to strain sensitivity or the rate at which the particles are released from the fibers .
Biofilm formation in the presence of nanofibers
Viable cell numbers recorded for P. aeruginosa PA01 and S. aureus Xen 30 were after 48 h approximately 5% less in the presence of CF, compared to cells grown in the absence of nanofibers (Fig 5A and 5C, respectively). The decline in cell numbers is attributed to adhesion of the two strains to nanofibers (CF), as shown in Fig 6A and 6C. Growth of P. aeruginosa PA01 declined with approximately 13% in the presence of Cu-F (Fig 5A) and growth of S. aureus Xen 30 with approximately 31% (Fig 5C). After 48 h in the presence of Cu-F, biofilm formation of P. aeruginosa PA01 decreased with approximately 41% (Fig 5B) and that of S. aureus Xen 30 with approximately 50% (Fig 5D), compared to biofilm formation in the absence of nanofibers and copper. Very few cells of P. aeruginosa PA01 and S. aureus Xen 30 adhered to Cu-F (Fig 6B and 6D). Based on these findings, copper that diffused from Cu-F inhibited cell growth and biofilm formation of S. aureus Xen 30 and P. aeruginosa PA01.
Cells not treated with copper and not cultured in the presence of nanofibers serves as control (labelled c). Incubation was at 37°C. Readings were taken at 3, 6, 24 and 48h. (a) Number of viable cells of P. aeruginosa PA01, (b) total biofilm formation by cells of P. aeruginosa PA01, (c) number of viable cells of S. aureus Xen 30 and (d) total biofilm formation by cells of S. aureus Xen 30. Biofilm formation was determined by staining with crystal violet and recording OD readings at 595 nm. Data points presented are the average of three independent experiments (mean ± standard deviation). * p< 0.05.
Images (a) and (c) show cell growth of P. aeruginosa PA01 and S. aureus Xen 30, respectively, on the surface of CF. Images (b) and (d) show cell growth of P. aeruginosa PA01 and S. aureus Xen 30, respectively, on the surface of Cu-F.
In a recent study, growth inhibition and biofilm formation of MRSA and P. aeruginosa were shown when the cells were treated with copper-containing nanoparticles (Cu-NPs) [25, 26]. Christina et al.  reported a 88% decrease in P. aeruginosa biofilm biomass and a 90% decrease in S. aureus biofilm biomass when treated with Cu-NPs. We did not determine changes in biomass, but recorded a drastic decline in biofilm formation based on crystal violet staining (41% for P. aeruginosa PA01 and 50% S. aureus Xen 30).
Confocal imaging of biofilms
Staining with LIVE/DEAD® BaclightTM and FilmTracerTM SYPRO® Ruby Biofilm Matrix Stain showed only few viable cells in the presence of Cu-F (Fig 7Ac and 7Bc), compared to many more viable cells detected in the presence of CF (Fig 7Ab and 7Bb). The intense fluorescence recorded with ruby stain of P. aeruginosa PA01 cells, incubated in the absence of nanofibers and copper, and in the presence of CF, may be due to the presence of a high concentration of glycoproteins, phosphoproteins, lipoproteins, calcium-binding proteins and fibrillar proteins in the biofilm. These proteins are difficult to stain. The intensity of fluorescence was directly proportion to the number of cells present in the biofilms.
LIVE/DEAD® BaclightTM and FilmTracerTM SYPRO® Ruby Biofilm Matrix Stain of 48-h-old biofilms of P. aeruginosa PA01 (A) and S. aureus Xen 30 (B). For each strain, images were taken of biofilms that formed in (a) the absence of nanofibers and copper, (b) nanofibers without copper particles (CF) and (c) copper-containing nanofibers (Cu-F). The images in column 1 is after propidium iodide staining, column 2 after ruby staining and column 3 after SYTO® 9 staining. The image in column 4 is an overlap of all stains.
Characterization of biofilms by SEM and AFM
Images of 48-h-old biofilms of P. aeruginosa PA01 and S. aureus Xen 30 recorded with SEM and AFM clearly showed inhibition of biofilm formation in presence of Cu-F (Fig 8Ac and f, and 8Bc and f). Surface colonization of cells with hydrocolloids and EPS was clearly visible in untreated (Fig 8Aa and d, and 8Ba and d) and CF-treated (Fig 8Ab and e, and 8Bb and e) biofilms. The development of biofilm architecture is highly important for the exchange of nutrients, pathogenicity and resistance to antimicrobial compounds . Our results confirmed that Cu-F controlled biofilm formation by inhibiting bacteria and the formation of extracellular matrix.
A: Scanning electron microscopy (SEM) images of P. aeruginosa PA01 biofilms (a, b and c) and S. aureus Xen 30 biofilms (d, e and f) that formed after 48 h on the polymer surfaces of the wells. B: Atomic force microscopy (AFM) images of P. aeruginosa PA01 biofilms (a, b and c) and S. aureus Xen 30 biofilms (d, e and f) that formed after 48 h on the polymer surfaces of the wells. Images a and d were taken from biofilms that formed in the absence of nanofibers and copper particles, b and e from biofilms that formed in the presence of CF, and c and f from biofilms that formed in the presence of Cu-F.
Controlled release of copper
An initial 773 μg of copper release was recorded, followed by a burst release of 1616 μg of copper after 2 h (Fig 9A). After 4 h, fluctuations in copper release were observed, with a stepwise decline after every 6 h (Fig 9A). This is ascribed to the gradual disintegration of the hydrophilic PEO from PDLLA in the PDLLA: PEO matrix and the formation of an amorphous matrix, as shown by Heunis and co-workers . Exposed copper particles in degraded nanofibers, shown in SEM images (insert, Fig 9A), supports the findings. The rate at which copper is released from solid surfaces depends on the releasing media. Low release rates were reported in water and phosphate buffer, whereas much higher release rates were recorded in Tris-Cl buffer and spent M17 medium . The sudden release of high concentrations of copper during the first 2 h is important to control infections and restrict biofilm formation by killing more planktonic cells. The burst release of copper is similar to that reported for nisin, 2,3-dihydroxybenzoic acid, Ag-NPs, and ciprofloxacin incorporated into PDLLA/PEO nanofibers [27, 31–34, 38].
A: Release of copper from PDLLA/PEO nanofibers. A SEM image of the electrospun nanofibers after the release of copper particles is shown in the insert. B: Percentage of MCF-12A breast epithelial cells that survived exposure to CF and Cu-F. Sterile culture medium served as negative control (NC). Data points presented are the average of three independent experiments (mean ± standard deviation). * p < 0.05.
Cytotoxicity of Cu-F
Survival of MCF-12A breast epithelium cells was significantly affected in the presence of Cu-F (Fig 9B). No changes in the viability of MCF-12A were recorded when the cells were exposed to CF, confirming the safety of PDLLA/PEO nanofibers . The 3% survival of cells in the presence of Cu-F indicated a higher sensitivity of breast epithelial cells towards copper, or a maximum release of copper particles in the media used in this study. Exposure of copper to skin induced far less adverse reactions . Further in vitro tests on keratinocytes and in vivo tests with rats or mice need to be performed.
Despite irregularity observed in the shape of the copper particles, they were successfully incorporated into PDLLA and PEO nanofibers and remained in crystal form. The encapsulated copper particles had no effect on the thermal behaviour of the nanofibers, even at an inclusion of 40 wt. %. Biofilm formation by P. aeruginosa PA01 and S. aureus Xen 30 may be controlled by the release of copper from the nanofibers. Furthermore, very few cells of P. aeruginosa PA01 and S. aureus Xen 30 adhered to the copper-containing nanofibers, suggesting that these nanofibers may be used to control initial cell growth in biofilms and possibly also infected wounds. Only a few breast epithelial cells (3%) survived exposure to copper-containing fibers, which suggests that the levels of copper released from the nanofibers were highly toxic to cells in tissue culture. Other studies have shown that copper concentrations at these levels have no adverse reaction when applied on human skin .
Conceived and designed the experiments: JA MH DPN LMTD. Performed the experiments: JA MH DPN. Analyzed the data: JA MH DPN LMTD. Contributed reagents/materials/analysis tools: JA MH DPN. Wrote the paper: JA MH DPN LMTD.
- 1. Borkow G, Gabbay J, Dardik R, Eidelman AI, Lavie Y, Grunfeld Y, et al. Molecular mechanisms of enhanced wound healing by copper oxide‐impregnated dressings. Wound Repair Regen. 2010;18: 266–275. pmid:20409151
- 2. Uauy R, Olivares M, Gonzalez M. Essentiality of copper in humans. Am J Clin Nutr. 1998;67: 952S–959S. pmid:9587135
- 3. Tenaud I, Sainte-Marie I, Jumbou O, Litoux P, Dreno B. In vitro modulation of keratinocyte wound healing integrins by zinc, copper and manganese. Brit J Dermatol. 1999;140: 26–34.
- 4. Sen CK, Khanna S, Venojarvi M, Trikha P, Ellison EC, Hunt TK, Roy S. Copper-induced vascular endothelial growth factor expression and wound healing. Am J Physiol Heart Circ Physiol. 2002;282: H1821–H1827. pmid:11959648
- 5. Rucker RB, Kosonen T, Clegg MS, Mitchell AE, Rucker BR, Uriu-Hare JY, Keen CL. Copper, lysyl oxidase, and extracellular matrix protein cross-linking. Am J Clin Nutr. 1998;67: 996S–1002S. pmid:9587142
- 6. Ahmed Z, Briden A, Hall S, Brown RA. Stabilisation of cables of fibronectin with micromolar concentrations of copper: In vitro cell substrate properties. Biomat. 2004;25: 803–812.
- 7. Harris ED, Rayton JK, Balthrop JE, Di Silvestro RA, Garcia‐de‐Quevedo M. Copper and the synthesis of elastin and collagen. Ciba Found Symp. 1980;79: 163–182. pmid:6110524
- 8. Quaranta D, Krans T, Espírito Santo C, Elowsky CG, Domaille DW, Chang CJ, Grass G. Mechanisms of contact-mediated killing of yeast cells on dry metallic copper surfaces. Appl Environ Microbiol. 2011;77: 416–426. pmid:21097600
- 9. Palza H. Antimicrobial polymers with metal nanoparticles. Int J Mol Sci. 2015;16: 2099–2116. pmid:25607734
- 10. Muhammad S, Mohamed E, Kamyar S, Norhazlin Z, Mohamed S, Ibrahim N. Synthesis, characterization, and antimicrobial properties of copper nanoparticles. Int J Nanomed. 2013;8: 4467–4479.
- 11. Gaggelli E, Kozlowski H, Valensin D, Valensin G. Copper homeostasis and neurodegenerative disorders (Alzheimer’s, prion, and Parkinson’s diseases and amyotrophic lateral sclerosis). Chem Rev. 1995;106: 1995–2044.
- 12. Lutsenko S, Barnes NL, Bartee MY, Dmitriev OY. Function and regulation of human copper-transporting ATPases. Physiol Rev. 2007;87: 1011–1046. pmid:17615395
- 13. Chatterjee AK, Chakraborty R, Basu T. Mechanism of antibacterial activity of copper nanoparticles. Nanotechnol. 2014;25: 135101.
- 14. Grass G, Rensing C, Solioz M. Metallic copper as an antimicrobial surface. Appl Environ Microbiol. 2011;77: 1541–1547. pmid:21193661
- 15. USEPA. EPA registers copper-containing alloy products. 2008. http://www.epa.gov/pesticides/factsheets/copper-alloy-products.htm.
- 16. Casey AL, Adams D, Karpanen TJ, Lambert PA, Cookson BD, Nightingale P, et al. Role of copper in reducing hospital environment contamination. J Hosp Infect. 2010;74: 72–77. pmid:19931938
- 17. Mehtar S, Wiid I, Todorov SD. The antimicrobial activity of copper and copper alloys against nosocomial pathogens and Mycobacterium tuberculosis isolated from healthcare facilities in the western cape: an in vitro study. J Hosp Infect. 2008;68: 45–51. pmid:18069086
- 18. Wheeldon LJ, Worthington T, Lambert PA, Hilton AC, Lowden CJ, Elliott TS. Antimicrobial efficacy of copper surfaces against spores and vegetative cells of Clostridium difficile: the germination theory. J Antimicrob Chemother. 2008;62: 522–525. pmid:18544601
- 19. Noyce JO, Michels HT, Keevil CW. Potential use of copper surfaces to reduce survival of epidemic methicillin-resistant Staphylococcus aureus in the healthcare environment. J Hosp Infect. 2006;63: 289–297. pmid:16650507
- 20. Tian WX, Shi Y, Muhammad I, Abdul WA, Liu H, Qiu H, et al. Copper as an atimicrobial agent against opportunistic pathogenic and multidrug resistant Enterobacter bacteria. J Microbiol. 2012;50: 586–593. pmid:22923106
- 21. Faundez G, Troncoso M, Navarrete P, Figueroa G. Antimicrobial activity of copper surfaces against suspensions of Salmonella enterica and Campylobacter jejuni. BMC Microbiol. 2004;4: 19. pmid:15119960
- 22. Wilks SA, Michels H, Keevil CW. The survival of Escherichia coli O157 on a range of metal surfaces. Int J Food Microbiol. 2005;105: 445–454. pmid:16253366
- 23. DeLeon S, Clinton A, Fowler H, Everett J, Horswill AR, Rumbaugh KP. Synergistic interactions of Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro wound model. Infect Immunol. 2014;82: 4718–4728.
- 24. Lewis K. The riddle of biofilm resistance. Antimicrob Agents Chemother. 2001;45: 999–1007. pmid:11257008
- 25. Lewis OF, Mubarak AD, Nithya C, Priyanka R, Gopinath V, Alharbi NS, et al. One pot synthesis and anti-biofilm potential of copper nanoparticles (CuNPs) against clinical strains of Pseudomonas aeruginosa. Biofouling 2015;31: 379–391. pmid:26057498
- 26. Christena LR, Mangalagowri V, Pradheeba P, Ahmed KBA, Shalini BIS, Vidyalakshmi M, et al. Copper nanoparticles as an efflux pump inhibitor to tackle drug resistant bacteria. RSC Advances 2015;5: 12899–12909.
- 27. Ahire JJ, Neveling DP, Dicks LMT. Co-spinning of silver nanoparticles with nisin increases the antimicrobial spectrum of PDLLA: PEO nanofibers. Curr Microbiol. 2015;71: 24–30. pmid:25855302
- 28. Wu J, Zheng Y, Song W, Luan J, Wen X, Wu Z et al. In situ synthesis of silver-nanoparticles/bacterial cellulose composites for slow-released antimicrobial wound dressing. Carbohydr Polym. 2014;102: 762–771. pmid:24507345
- 29. Dolina J, Jiříček T, Lederer T. Membrane modification with nanofiber structures containing silver. Ind Eng Chem Res. 2013;52: 13971–13978.
- 30. Heunis TDJ, Botes M, Dicks LMT. Encapsulation of Lactobacillus plantarum 423 and its bacteriocin in nanofibers. Probiotics & Antimicrob Prot. 2010;2: 46–51.
- 31. Ahire JJ, Neppalli R, Heunis TD, van Reenen AJ, Dicks LMT. 2, 3-Dihydroxybenzoic acid electrospun into poly (D, L-lactide)(PDLLA)/poly (ethylene oxide)(PEO) nanofibers inhibited the growth of Gram-positive and Gram-negative bacteria. Curr Microbiol. 2014;69: 587–593. pmid:24934995
- 32. Ahire JJ, Dicks LMT. 2, 3-Dihydroxybenzoic acid-containing nanofiber wound dressings inhibit biofilm formation by Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2014;58: 2098–2104. pmid:24449781
- 33. Ahire JJ, Dicks LMT. Nisin incorporated with 2, 3-Dihydroxybenzoic acid in nanofibers inhibits biofilm formation by a methicillin-resistant strain of Staphylococcus aureus. Probiotics & Antimicrob Prot. 2015;7: 52–59.
- 34. Ahire JJ, Neveling DP, Hattingh M, Dicks LMT. Ciprofloxacin-eluting nanofibers inhibits biofilm formation by Pseudomonas aeruginosa and a methicillin-resistant Staphylococcus aureus. PLoS ONE 2015;10(4): e0123648. pmid:25853255
- 35. Sheikh FA, Kanjwal MA, Saran S, Chung WJ, Kim H. Polyurethane nanofibers containing copper nanoparticles as future materials. Appl Surf Sci. 2011;257: 3020–3026.
- 36. Ding B, Wang M, Wang X, Yu J, Sun G. Electrospun nanomaterials for ultrasensitive sensors. Mater Today 2010;13: 16–27.
- 37. JCPDS, card no (1953) 04–0836.
- 38. Heunis TD, Bshena O, Klumperman B, Dicks LMT. Release of bacteriocins from nanofibers prepared with combinations of poly (D, L-lactide)(PDLLA) and poly (ethylene oxide)(PEO). Int J Mol Sci. 2011;12: 2158–2173. pmid:21731433
- 39. Elguindi J, Wagner J, Rensing C. Genes involved in copper resistance influence survival of Pseudomonas aeruginosa on copper surfaces. J Appl Microbiol. 2009;106: 1448–1455. pmid:19239551
- 40. Ren G, Hu D, Cheng EW, Vargas-Reus MA, Reip P, Allaker RP. Characterisation of copper oxide nanoparticles for antimicrobial applications. Int J Antimicrob Agents 2009;33: 587–590. pmid:19195845
- 41. Denyer SP, Maillard JY. Cellular impermeability and uptake of biocides and antibiotics in Gram-negative bacteria. J Appl Microbiol. 2002;92: 35S–45S. pmid:12000611
- 42. Yousuf B, Ahire JJ, Dicks LMT. Understanding the antimicrobial activity behind thin-and thick-rolled copper plates. Appl Microbiol Biotechnol. 2016;
- 43. Lemire JA, Harrison JJ, Turner RJ. Antimicrobial activity of metals: mechanisms, molecular targets and applications. Nature Rev Microbiol. 2013;11: 371–384.
- 44. Molteni C, Abicht HK, Solioz M. Killing of bacteria by copper surfaces involves dissolved copper. Appl Environ Microbiol. 2010;76: 4099–4101. pmid:20418419
- 45. Flemming HC, Wingender J. The biofilm matrix. Nature Rev Microbiol. 2010;8: 623–633.
- 46. Hostynek JJ, Maibach HI. Copper hypersensitivity: dermatologic aspects-an overview. Rev Environ Health 2003;18: 153–183. pmid:14672513